Latest Lentivirus Stories
GREENWICH, Conn., Aug.
BERGISCH GLADBACH, Germany, August 14, 2014 /PRNewswire/ -- Addition of lentiviral gene delivery capabilities complements strategic partnering portfolio.
A recent study published in the Neural Regeneration Research (Vol. 8, No. 17, 2013) injected recombinant lentivirus carrying enhanced green fluorescent protein and the target gene Atoh1 into the cochlea of normal rats using a postauricular approach via the round window membrane.
Using a combination of evolutionary biology and virology, scientists at Fred Hutchinson Cancer Research Center have traced the birth of the ability of some HIV-related viruses to defeat a newly discovered cellular-defense system in primates.
In a paper published in the October 2011 issue of Experimental Biology and Medicine, a team of researchers at Columbia University Medical Center led by Stephen Tsang, MD, Ph.D have achieved temporary functional preservation of photoreceptors in a mouse model for retinitis pigmentosa (RP) using novel bipartite gene therapy.
Could glowing, fluorescent green cats be the next great weapon in the fight against AIDS and the HIV virus?
In what represents an important step toward curing HIV, a USC scientist has created a virus that hunts down HIV-infected cells.
In its continuing support of the DECIPHER Projectâ€”an open access platform for genome-wide RNAi screening and analysis, Cellecta released the 3rd DECIPHER shRNA Expression Library Module which targets an additional 5,000 human genes enabling researchers to now analyze the functionality of over 15,000 human genes for various biological processes with all three human modules. Mountain View, CA (PRWEB) February 25, 2011 Today, Cellecta, Inc.
A method for interfering with disease genes in experimental animals will enhance drug discovery for cancer and other disorders.
- The governor of a province or people.